PANACEA BIOTEC LTD. - Intimation Of Suit Filed By Panacea Biotec Limited ('Company') Against Sanofi Healthcare India Private Limited

We would like to inform you that the Company has instituted a suit before the Hon'ble Delhi High Court seeking to restrain Sanofi Healthcare India Private Limited from marketing a fully liquid hexavalent vaccine that would infringe Company's patent for its fully liquid Whole Cell Pertussis based fully liquid Hexavalent Vaccine, EasySixTM. <BR> <BR> Panacea Biotec's EasySixTM is a first of its kind Whole Cell Pertussis based fully liquid Hexavalent Vaccine which comes in a pre-filled syringe and is used to vaccinate against, Diphtheria, Tetanus, Whooping Cough, Hepatitis B, Haemophilus influenza type b and Inactivated Polio (DTwP-HepB-Hib-IPV). EasySixTM has been in the market since 2017. <BR> <BR> A brief note in respect of the above mentioned matter is enclosed herewith for your kind information and record please.<BR> <BR> Kindly acknowledge the receipt.<BR>